We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04270175
Brief Title: Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

First Submitted : February 12, 2020
First Submitted that Met QC Criteria : February 12, 2020
First Posted : February 17, 2020

Last Update Submitted that Met QC Criteria : June 8, 2022
Last Update Posted : June 9, 2022